|
|
||||||||
-induced cholecystokinin type A receptor expression in the female mouse pituitary
1 Division of Clinical and Reproductive Sciences, Department of Clinical Sciences, University of Kentucky, Lexington, Kentucky 40536, USA 2 Department of Anatomy and Neurobiology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, South Korea Departments of 3 Biology and 4 Animal Sciences, University of Kentucky, Lexington, Kentucky 40536, USA 5 Institut de Genetique et de Biologie Moleculaire et Cellulaire (CNRS, INSERM, ULP, College de France) and Institut Clinique de la Souris, BP10142, 67404 Illkirch-Strasbourg, France
(Correspondence should be addressed to C Ko; Email: cko2{at}uky.edu) http://www.mc.uky.edu/CLS/ko/default.htm
Estrogen plays a critical role in inducing LH surge. In the pituitary, estrogen receptor
(ER
) mediates the action of estrogen, while the downstream pathway of ER
activation is yet to be elucidated. Here, we report the finding that cholecystokinin type A receptor (CCK-AR) is an ER
downstream gene in the mouse anterior pituitary. In the cycling mouse pituitary, the expression of CCK-AR mRNA is markedly higher in the afternoon of proestrus compared with metestrus. Both ovariectomy (OVX) and null mutation of the ER
gene completely abolish CCK-AR mRNA expression. Injection of 17ß-estradiol to OVX wild-type mice induces recovery of CCK-AR mRNA expression to levels observed at proestrus, but no such recovery is induced in OVX ER
knockout mice. The same pattern of estrogen dependency in inducing CCK-AR mRNA expression was seen in cultured primary anterior pituitary cells, indicating that estrogen directly acts on pituitary cells to induce CCK-AR expression. Immunohistological analysis revealed that more than 80% of gonadotrophs express CCK-AR in the afternoon of proestrus. To test whether CCK-AR mediated the sensitizing effect of estrogen in GnRH-induced LH secretion, primary pituitary cells were primed with estrogen followed by treatment with GnRH in the presence or absence of lorglumide, a CCK-AR antagonist. While both groups secreted LH upon GnRH treatment, lorglumide treatment significantly decreased LH secretion. Taken together, this study finds CCK-AR to be an ER
downstream gene in the pituitary and suggests that CCK-AR may play a role in the estrogen sensitization of the pituitary response to GnRH.
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |